Sun Pharma has announced that it has commenced Phase II clinical trial on AQCH, a phytopharmaceutical (plant-derived) drug.
The post Dengue drug enters Phase II clinical trial for COVID-19 appeared first on BioTech Times.
About the Author: Biotech Today
You might like
Oral and Nasal Covid-19 Vaccines Hit Clinical Testing
3 days ago
4 Likes
12
Tracking Covid-19 Cases with Wastewater DNA Testing
1 week ago
4 Likes
23